行情

GLPG

GLPG

Galapagos
NASDAQ

实时行情|Nasdaq Last Sale

85.14
+0.49
+0.58%
盘后: 85.14 0 0.00% 16:00 02/25 EST
开盘
86.75
昨收
84.65
最高
86.75
最低
84.62
成交量
24.77万
成交额
--
52周最高
247.43
52周最低
81.89
市值
55.69亿
市盈率(TTM)
-14.5968
分时
5日
1月
3月
1年
5年
新闻
财报
公告
公司事件
分析
简况
史蒂芬·科恩(Steven Cohen)跳入Chimerix
Steven Cohen Dives Into Chimerix, Stocks: CMRX,ALNY,DRNA,MRTX,GLPG,CRIS,AGLE,ATRA,BLU,BDTX, Steven Cohen, release date:Feb 24, 2021
GuruFocus.com · 1天前
肺纤维化药物市场有望在2020-2027年间取得显着增长| Ameco Research
pune, India, Wed, 24 Feb 2021 07:06:43 / Comserve Inc. / -- Pulmonary fibrosis is a lung disorder characterized by damage or scarring of the lung tissue....
Comserve · 1天前
顶级分析师升级和降级:Advance Auto,Dish Network,Intuit,Kroger,Palo Alto,Starbucks,Texas Instruments等
247WallSt.com · 2天前
雷蒙德·詹姆斯(Raymond James)将加拉帕戈斯(Galapagos)升级为跑赢大盘,宣布目标价为100美元
Raymond James analyst Dane Leone upgrades Galapagos (NASDAQ:GLPG) from Market Perform to Outperform and announces $100 price target.
Benzinga · 3天前
加拉帕戈斯群岛:尽管临床试验失败,仍有向上的选择性
Galapagos (GLPG) is far from a household name in the US, yet it remains a productive company that warrants further review. GLPG burst onto the scene in 2015 when it
TipRanks.com · 3天前
社区获得的耐甲氧西林金黄色葡萄球菌(CA-MRSA)药物市场分析,规模,份额,趋势和预测2020-2027
pune, India, Mon, 22 Feb 2021 06:24:21 / Comserve Inc. / -- Community Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Drug market is segmented...
Comserve · 3天前
分析师对医疗保健公司提供见解:加拉帕戈斯(GLPG)和同源医学(FIXX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG) and Homology Medicines (FIXX). Galapagos
SmarterAnalyst · 4天前
全球慢性炎性脱髓鞘性多发性神经病治疗市场Covid-19对2021年医疗保健行业的影响分析,规模,趋势,增长,份额,业务,关键参与者,合并,统计,竞争态势以及到2028年的区域预测
Feb 18, 2021 (The Expresswire) -- Chronic Inflammatory Demyelinating Polyneuropathy Therapeutics Market | 2021 Healthcare Sector Global Analysis By Covid-19...
The Express Wire · 6天前
更多
财务预测
每股收益每股净资产每股现金流
实际值(美元)
预测值(美元)
利润表更多
净利润营业总收入营业利润
净利润(美元)
同比(%)
资产负债表更多
总资产(美元)
总负债(美元)
资产负债率(%)
现金流表更多
经营现金流投资现金流筹资现金流
经营现金流(美元)
同比(%)
了解GLPG最新的财务预测,通过GLPG每股收益,每股净资产,每股现金流等数据分析Galapagos近期的经营情况,然后做出明智的投资选择。
分析师评级

10位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测
分析师预测GLPG价格均价为95.56,最高价位128.98,最低价为76.99。
EPS
机构持股
总机构数: 237
机构持股: 637.90万
持股比例: 9.75%
总股本: 6,541.18万
类型机构数股数
增持
38
145.97万
建仓
56
-250.88万
减持
35
180.35万
平仓
0
0
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
生物技术和医学研究
-2.53%
制药与医学研究
-1.34%
高管信息
Chairman - Management/Chief Executive Officer/Executive Director
Onno van de Stolpe
Non-Executive Chairman
Raj Parekh
Non-Executive Chairman
Rajesh Parekh
Chief Financial Officer/Chief Operating Officer/Executive Board
Bart Filius
Chief Scientific Officer/Executive Board
Piet Wigerinck
Executive Board
Walid Abi-Saab
Vice President/IR Contact Officer
Elizabeth Goodwin
Executive Board
Andre Hoekema
Non-Executive Independent Director
Katrine Bosley
Non-Executive Director
Harrold van Barlingen
Non-Executive Independent Director
Werner Cautreels
Non-Executive Independent Director
Mary Kerr
Non-Executive Independent Director
Christine Mummery
  • 分红
  • 拆股
  • 内部人交易
暂无数据
GLPG 简况
Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company aims to develop a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. In addition, the Company’s mission is to develop a number of medicines based on the discovery of novel targets. Galapagos NV also discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. Galapagos aims to develop small molecules that inhibit these targets, restore the balance and thereby positively influence the course of the disease.

微牛提供Galapagos NV(NASDAQ-GLPG)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的GLPG股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易GLPG股票基本功能。